Tag: chemistry
-
Vaccine Shown to Protect Against Multiple Hospital Pathogens
Research with lab mice shows an experimental vaccine stimulates the body’s basic immune system to protect against a range of pathogens associated with hospital infections.
-
Biomanufacturing Company Gains $9.5M in Early Funds
A company offering a biomanufacturing process it says is more efficient and scalable than conventional bio-production methods is raising $9.5 million in its first venture round.
-
Biotech, Univ. Labs Test Psychoactive Drug as PTSD Therapy
A developer of treatments with psychedelic compounds for brain disorders is partnering with a lab at Yale University to assess methylone as a PTSD therapy.
-
Biosensor Developed to Detect Explosives, Land Mines
Researchers from a university biochemistry lab and company developing synthetic enzymes designed techniques using engineered bacteria to detect buried land mines at longer distances.
-
Small Biz Grant Supports Regenerative Alzheimer’s Treatment
A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease.
-
Neurons from Stem Cells Produced for Overdose Therapy Tests
Researchers use stem cells to generate human neurons resembling those in the brain that control breathing during opioid reactions, for eventual chip devices to test overdose therapies.
-
What Science Has to Say About CBD
If you’ve used CBD for these reasons above, you might enjoy peace of mind knowing scientists have found the possible benefits you’ve known all along.
-
Trial Begins for Multi-Neurological Disease Therapy
A clinical trial is underway testing a new type of therapy its developer says addresses damage to nerve cells associated with a number of neurological disorders.
-
Company Gains Ultrasound-Linked Drug Capsule Technology
A company developing a drug delivery process with treatments activated by ultrasound received an option to license a key technology from its founders’ university labs.
-
Long-Acting Drug Start-Up Raises $4M in Seed Funds
A new company with a process using artificial intelligence and robotics to speed development of sustained release drugs is raising $4 million in seed funds.